LEO Pharma’s Country Lead for Switzerland, Patrick Brunner, discusses the skincare specialist’s most important products, the Swiss affiliate’s significance to the global group, and the exciting new partnership with AstraZeneca.
LEO Pharma Switzerland was established back in 1991 meaning that, last year, you celebrated 25 years of in-country operations. Could you please start by giving us a sense of the scope of your activities within Switzerland and how they have evolved over time?
"Enhanced competition is actually a phenomenon that we welcome, because it keeps us on our toes, in a state of constant innovation, and ensures good outcomes for patient"
